| Literature DB >> 33554149 |
M Sadman Sakib1, Godwin Sokpor2, Huu Phuc Nguyen2, Andre Fischer1,3, Tran Tuoc2.
Abstract
Cell sorting can be used to purify cell populations for cell type-specific molecular probing. Fluorescence-activated cell sorting (FACS) coupled with high-throughput sequencing affords molecular signature identification for specific cell types. FACS has many challenges that limit comprehensive cell purification from the brain, leading to incomplete molecular characterization. Here, we present the intranuclear immunostaining-based FACS protocol with several modified steps, which allows optimized nuclei/cell sorting from mouse or human embryonic cortical tissue for distinct downstream molecular investigation of basal intermediate progenitors.Entities:
Keywords: Flow Cytometry/Mass Cytometry; Genomics; Neuroscience
Mesh:
Year: 2021 PMID: 33554149 PMCID: PMC7859298 DOI: 10.1016/j.xpro.2021.100318
Source DB: PubMed Journal: STAR Protoc ISSN: 2666-1667
Figure 1FACS gating strategy for mouse and human TBR2 sorting
First P1 is selected to get all nuclei separated from debris, then P2 and P3 population is selected for single nuclei, rejecting doublets, or multiplets. For mouse (A), since the TBR2 population was rather smear like, instead of completely separated population, TBR2+ gating was done conservatively to make sure no TBR2- nuclei mis-sorted. This heavily depends upon sorting efficiency and accuracy of a given FACS machine. (B) Human TBR2 sorting.
Figure 2Post sorting validation for sorting efficiency
Notice that in TBR2− nuclei, there is no signal, while all TBR2+ DAPI nuclei have an Alexa 488 (green) signal, confirming 100% pure population. Scale bar, 5 μm.
Figure 3Bioanalyzer image of sorted TBR2 nuclear RNA
Notice the unusually low amount of 18S rRNA, which results in an unmeasurable RNA integrity number (RIN). However, intact 28S rRNA and no visible degraded RNA in regions between 200 and 2000 nucleotide shows no apparent RNA degradation.
Figure 4Oak ridge tube nuclei pellet after centrifugation
Take note of the ring-shaped pellet forming instead of a regular pellet at the bottom.
| REAGENT or RESOURCE | SOURCE | IDENTIFIER |
|---|---|---|
| Alexa Fluor 488-conjugated rat EOMES/TBR2 antibody | eBioscience | 53-4875-82 (Clone: Dan11mag) |
| Alexa Fluor 488 | Invitrogen | A-11006; RRID: AB_221544 |
| E13.5–E16.5 mouse cortical tissue | Charles River Laboratories | CD-1 IGS |
| GW14–GW20 human cortical tissue | Medical University-Varna | N/A |
| Nuclei EZ prep lysis buffer | Sigma | NUC101-1KT |
| BSA, RNase free | Merck | 2905-5GM |
| BSA, fraction V | Roth | 8076.4 |
| Complete Protease inhibitor cocktail EDTA free | Roche | 4693132001 |
| RNasin Plus RNase inhibitor | Promega | N2615 |
| 10× PBS, RNase free | Invitrogen | AM9625 |
| DPBS, w/o Ca and Mg | PAN-Biotech | P04-361000 |
| Sucrose for molecular biology | Sigma | S0389 |
| Calcium chloride (CaCl2) | Roth | 5239.2 |
| Magnesium acetate (MgAc2) | Roth | P026.1 |
| EDTA (0.5 M), pH 8.0 | Invitrogen | AM9260G |
| HEPES (1 M) | Gibco | 15630056 |
| Triton X-100 | Sigma | T8787 |
| Tween 20 | Sigma | P9416-50ML |
| 1,4-Dithiothreitol (DTT) | Roth | 6908.3 |
| RNase-free molecular biology grade water | Sigma | W4502-1L |
| TRIzol LS reagent | Invitrogen | 10296010 |
| Trichloromethane/chloroform | Roth | 4432.1 |
| Ethanol | Roth | 9065.1 |
| RNA 6000 Pico Bioanalyzer Kit | Agilent | 5067-1513 |
| Qubit RNA HS Assay Kit | Invitrogen | Q32852 |
| SMART-Seq v4 Ultra Low Input RNA Kit for sequencing | Takara | 634888 (for 12 reactions) |
| Nextera XT DNA Library Preparation Kit | Illumina | FC-131-1024 |
| 37% Formaldehyde solution | Sigma | F8775 |
| Glycine (1.25 M stock) | Millipore | 357002 |
| NEBNext Ultra II DNA Library Prep Kit for Illumina | NEB | E7645S |
| Foxp3/Transcription Factor Staining Buffer Set | eBioscience | 00-5523 |
| Neural tissue dissociation kit | MACS Miltenyi Biotec | 130-092-628 P |
| RNaseZap | Ambion | 9780.9782 |
| RNeasy Mini Kit | Qiagen | Cat#74104 |
| Fetal calf serum (FCS) | Sigma | C8056 |
| PBS (1×) | Invitrogen | Cat#20012-019 |
| SUPERase⋅In RNase Inhibitor (20 U/μL) | Invitrogen Thermo Fisher | Cat#AM2696, 2,500 units |
| Complete (protein inhibitors) | Roche | Mini: #1 836 153 |
| BD FACS Aria III sorter | BD Biosciences | |
| Falcon tube roller mixer | Stuart | SRT9D |
| 2100 Bioanalyzer Instrument | Agilent | G2939BA; RRID:SCR_018043 |
| Qubit 4 fluorometer | Invitrogen | Q33238; RRID:SCR_018095 |
| T 10 basic ULTRA-TURRAX | IKA | 0003737000 |
| S10N-5G dispersing tool for ULTRA-TURRAX | IKA | 0003304000 |
| Sterile syringe filter unit, 0.22 μm, PES, 33 mm | Millipore | SLGP033RS |
| DNA LoBind tubes (1.5 mL) | Eppendorf | 0030108051 |
| DNA LoBind tubes (2 mL) | Eppendorf | 0030108078 |
| Oak ridge PSF tubes | Thermo | 3137-0050 |
| 70 μm cup-type strainer (sterile) | BD Medimachine | 340633 |
| Aluminum heating/cooling block | Sigma | Z743497 |
| Falcon 5 mL round bottom polystyrene test tube, with cell strainer snap cap | Corning | 352235 |
Nuclei suspension buffer (NSB) for sorted nuclear RNA: (5,500 μL/sample required)
| Reagent | Unit | Stock conc | Final conc |
|---|---|---|---|
| BSA, RNase free | % | Powder | 0.5 |
| 10× PBS | x | 10 | 1.00 |
| RNasin Plus RNase inhibitor | x | 100 | 0.5 |
| Protease inhibitor | x | 100 | 1 |
Low Sucrose Buffer (LSB): (1,500 μL/sample needed)
| Reagent | Units | Stock concentration | Final concentration |
|---|---|---|---|
| Sucrose (342.3 g/mol) | mM | powder | 320 |
| CaCl2 | mM | 2,500 | 5 |
| MgAc2 | mM | 300 | 5 |
| EDTA | mM | 500 | 0.1 |
| HEPES | mM | 1,000 | 10 |
| Triton X-100 | % | 10 | 0.1 |
| Protease inhibitor (PI)∗ | x | 100 | 1 |
| DTT∗ | mM | 500 | 1 |
High Sucrose buffer (HSB): 6,000 μL/sample needed
| Reagent | Units | Stock concentration | Final concentration |
|---|---|---|---|
| Sucrose (342.3 g/mol) | mM | powder | 1,000 |
| MgAc2 | mM | 300 | 3 |
| HEPES | mM | 1,000 | 10 |
| DTT∗ | mM | 500 | 1 |
| Protease inhibitor(PI)∗ | x | 100 | 1 |
PBS containing Tween and BSA (PBTB): 3,500 μL/sample needed
| Reagent | Units | Stock concentration | Final concentration |
|---|---|---|---|
| BSA, fraction V | % | Powder | 1 |
| Tween 20 | % | 20 | 0.2 |
| Protease inhibitor(PI)∗ | x | 100 | 1 |
| DPBS (1×) | x | Use as a diluent for the whole buffer | |